Quantcast

Latest congenital heart disease Stories

2014-03-27 23:29:49

Flood Law Group issued a statement today explaining that they are now available to investigate potential legal claims on behalf of parents of children with heart-related birth defects who took Zoloft during their pregnancy. According to a study from the New England Journal of Medicine, selective serotonin reuptake inhibitors (SSRIs) such as Zoloft have been linked to an increased risk of birth defects. Washington, DC (PRWEB) March 27, 2014 Flood Law Group today announced that they are now...

2014-03-14 23:26:08

HALVE a Heart For Kids! A fundraiser for Greg Olsen's HEARTest Yard Fund — 10 percent of the proceeds of sales at Chili's Grill and Bar on March 18th will benefit Greg Olsen's HEARTest Yard Fund. Charlotte, NC (PRWEB) March 14, 2014 Over 50 Chili’s Grill and Bar restaurants in North Carolina and South Carolina will be participating in an all-day fundraiser to help families with children who have congenital heart disease on Tuesday, March 18. The money raised will go...

2014-02-27 23:04:25

Medical professionals from around the world gathered in Orlando, Fla. to present research updates, discuss patient management and advances in the field of cardiology from before birth through adulthood at Cardiology 2014 Philadelphia, Pa. (PRWEB) February 27, 2014 An international group of more than 1000 medical experts gathered at the nation’s largest pediatric cardiology conference from Feb. 19-23 to discuss the latest innovations in detection and treatment of congenital heart disease...

2014-02-26 16:27:17

AMHERST, N.Y., Feb. 26, 2014 /PRNewswire/ -- ONY, Inc., a pioneer in neonatal pharmaceutical development, has reached an agreement with Recordati Rare Diseases to co-promote NeoProfen(®) (ibuprofen lysine) Injection. (Logo: http://photos.prnewswire.com/prnh/20140226/CL72787LOGO ) NeoProfen® is indicated to close a clinically significant Patent Ductus Arteriosis (PDA) in premature infants weighing between 500 and 1500 grams, who are no more than 32 weeks gestational age when...

2014-02-24 12:27:03

Simple, non-invasive $4 test detects critical heart defects OVERLAND PARK, Kan., Feb. 24, 2014 /PRNewswire-USNewswire/ -- A simple test could save a child's life, but hospitals in Kansas are not required to offer it. This inexpensive, easy, lifesaving test to detect critical congenital heart defects, known as pulse oximetry, is required in more than 30 states across the country including Missouri. The Kansas Department of Health and Environment currently recommends that pulse...

2014-02-24 12:25:31

Variations as much as nine-fold in some cases, reinforces need for standardized practices to cut costs and improve quality, says new study ANN ARBOR, Mich., Feb. 24, 2014 /PRNewswire-USNewswire/ -- Costs of care differ significantly across hospitals for children born with heart defects, according to new research led by a University of Michigan researcher. Congenital heart defects are known to be the most common birth defects, impacting nearly 1 in every 100 births. The cost of care...

2014-02-14 23:02:37

Dr. Nilas Young, World of Children Award Honoree, is on a mission to ensure every child has access to life-saving cardiac care. San Francisco, CA (PRWEB) February 14, 2014 Every year, 1.3 million babies are born with a congenital heart defect, the most common birth defect in the world. However, nearly 90% of the world’s children lack access to life-saving heart care. Fortunately, heroes like Dr. Nilas Young, recipient of the 2012 World of Children Health Award, are ensuring more...

2014-02-05 08:30:39

ATLANTA, Feb. 5, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2013 fourth quarter and year end financial results will be released on Thursday, February 20, 2014. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson,...

2014-01-10 08:24:18

SEOUL, Korea, Jan. 10, 2014 /PRNewswire/ -- Mezzion Pharma Co. Ltd., announced that it has signed an agreement with New England Research Institutes, Inc., who are authorized by the National Heart, Lung, and Blood Institute-supported Pediatric Heart Network (PHN) to manage and conduct clinical trials on its behalf. The clinical studies to be conducted under this agreement were developed by a subcommittee made up of representatives of the PHN. The studies will be funded by a grant...

Bio-inspired Glue May Improve How Surgeons Treat Congenital Heart Defects And Other Heart Problems
2014-01-09 10:43:36

Brigham and Women's Hospital When a child is born with a heart defect such as a hole in the heart, the highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart. Sutures take too much time to stitch and can cause stress on fragile heart tissue, and currently available clinical adhesives are either too toxic or tend to lose their sticking power in the presence of blood or under dynamic conditions, such as in a beating heart....


Latest congenital heart disease Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.